Skip to main content

Momentive moves to speciality silicones

Momentive Performance Materials has outlined what it calls “a series of steps to accelerate its global transition from commodity basics chemicals to speciality silicones”. By the end, it expects to have 300 fewer employees in the Capital Region, where it is also considering investment in R&D facilities.

Ineos launches sanitiser business

Ineos used the occasion of the British Grand Prix on 1 August, where it was sponsoring the Mercedes team, to launch Ineos Hygienics, its new global healthcare business. This will be based at Newton Aycliffe, UK, and produce hospital grade hand gels, sanitiser sprays for hands and surfaces and sanitiser wipes out of the facilities the firm converted earliest this year here and in France, Germany and the US.

BASF to calculate full product carbon footprint

BASF has announced plans to provide total product carbon footprints (PCFs), measuring CO2 emissions for all of its 45,000 sales products. It has been doing this for individual products since 2007 and, using an in-house digital system, will do this for the full range by the end of 2021.

Croda begins building North America HQ

Croda International has started construction on its North American headquarters and innovation centre near Princeton, New Jersey. Due to be completed before the end of 2020, this will bring together commercial and technical teams from across its business areas, enabling Croda to further optimise collaboration with customers in North America.  

Croda begins building North America HQ

Croda International has started construction on its North American headquarters and innovation centre near Princeton, New Jersey. Due to be completed before the end of 2020, this will bring together commercial and technical teams from across its business areas, enabling Croda to further optimise collaboration with customers in North America.  

More CDMOs in COVID-19 deals

The ongoing race to develop the first effective vaccines for the treatment of COVID-19 continues to generate manufacturing and development agreements between pharmaceutical giants, biotechs and CDMOs.

Most recently, Sterling Pharma Solutions agreed to carry out final purification of drug product for Moleculin Biotech’s WP1122 drug candidate from its site in Cary, North Carolina. Moleculin is about to submit an IND for this to the FDA and wanted a reliable source of supply in the US.

Kodak enters pharma with government loan

The US International Development Finance Corporation (DFC) has signed a letter of interest to provide a $765 million loan to Eastman Kodak to support the launch of Kodak Pharmaceuticals at a ceremony at the company’s main site in Rochester, New York state. It was addressed remotely by President Trump and State Governor Andrew Cuomo.

Subscribe to Current issue